特一藥業 (002728.SZ)

7.75 +0.02 (+0.26%) 收市：03:04PM CST

特一藥業

No. 9, 11, Changxing Road
Taicheng
Taishan 529200
China
86 75 0562 7588
https://www.tczy.com.cn

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Songqing Xu	Deputy General Manager & Vice Chairman of The Board	無	無	1970
Mr. Xiliang Chen	CFO, Deputy GM, Board Secretary & Director	無	無	1972
Ms. Yanling Huang	Deputy General Manager	無	無	1962

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of proprietary Chinese medicines, chemical preparations, raw materials, and products in the People's Republic of China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular and cerebrovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. Teyi Pharmaceutical Group Co.,Ltd was founded in 2002 and is based in Taishan, the People's Republic of China.

公司管治

截至 無 止，特一藥業 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。